DSF Board Members

DSF Board Members

social 5x7 3A3A6973 copy e1696507312578

Gail Farfel, PhD

Gail brings more than 25 years of pharmaceutical development and regulatory rare disease experience with both large and small pharmaceutical companies. She is the chief executive officer of ProMIS, a biotechnology company focused on the generation of antibody therapeutics for neurodegenerative diseases. Gail was formerly the executive vice president and global chief development officer at […]

Gail Farfel, PhD Read More »

Scroll to Top
Skip to content